Narenda Kanuru, MD
Clinical Cardiac Electrophysiology · Marietta, GANPI 1538137047
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $23,407 of the $33,504 with a category attached, or 69.9%. 23 manufacturers reported payments, led by Medtronic at 49.5% of the total. 2025 is the largest year on record at $7,707, 2.0 times the $3,853 reported in 2019.
Across 540 payments — averaging $62.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$17K
- Atricure, Inc.$6K
- Abbott$4K
- Medical Device Business Services, Inc.$1K
- Boston Scientific$1K
- EBR Systems, Inc.$1K
- plus $3K from 17 others
Across 38 payments — averaging $2159.01 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Medtronic$66K
- Boston Scientific$16K
What the payments were for
- Travel & lodging$10,09730%
- Food & beverage$23,40770%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic(3 entities) | 294 | $16,596 |
| Atricure, Inc. | 48 | $5,839 |
| Abbott | 49 | $3,570 |
| Medical Device Business Services, Inc. | 12 | $1,499 |
| Boston Scientific | 29 | $1,425 |
| EBR Systems, Inc. | 10 | $1,240 |
| ZOLL Respicardia, Inc. | 5 | $1,051 |
| E.r. Squibb & Sons, L.L.C. | 18 | $283 |
| Pfizer | 16 | $268 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 11 | $265 |
| Kestra Medical Technology Services, Inc. | 7 | $251 |
| W. L. Gore & Associates, Inc. | 10 | $208 |
| Johnson & Johnson | 9 | $179 |
| Cardiva Medical, Inc. | 3 | $167 |
| Impulse Dynamics (USA) Inc. | 1 | $156 |
| Elutia, Inc. | 1 | $144 |
| Sanofi-aventis U.S. LLC | 8 | $130 |
| Cvrx, Inc. | 1 | $83 |
| Boehringer Ingelheim | 3 | $54 |
| Novo Nordisk | 2 | $47 |
| Amarin Pharma, Inc. | 1 | $20 |
| Lundbeck LLC | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX$3,766
- Micra$3,236
- Carto 3 System$1,199
- remede System$886
- DIAMONDTEMP BIDIRECTIONAL ABLATION CATHETER$779
- SYNERGY ABLATION SYSTEM$733
- ATRICLIP LAA EXCLUSION SYSTEM$667
- ENSITE PRECISION$652
- AFFERA MAPPING SYSTEM$635
- Arctic Front$570
- SelectSecure$503
- AURORA EV-ICD MRI SURESCAN$425
- NA$424
- EnSite Precision Cardiac Mapping System$373
- AMPLATZER Occluders$343
- JOT DX$328
- ADVISOR$327
- COBALT DR MRI SURESCAN$320
- OPTIMIZER$312
- AZURE XT DR MRI SURESCAN$210
How this compares
$33,504 in reported general payments places this provider in the 60th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
See all clinical cardiac electrophysiology providers in Georgia →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 544 | $663,906 |
| XareltoRivaroxaban | 160 | $195,586 |
| MultaqDronedarone Hcl | 15 | $32,932 |
| Flecainide Acetate | 196 | $9,639 |
| Dofetilide | 33 | $8,445 |
| SotalolSotalol Hcl | 335 | $6,765 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 158 | $4,318 |
| Amiodarone Hcl | 142 | $2,658 |
| Propafenone Hcl | 16 | $2,145 |
| Metoprolol Succinate | 134 | $1,560 |
| Mexiletine Hcl | 14 | $1,079 |
| Metoprolol Tartrate | 107 | $600 |
| Cartia XtDiltiazem Hcl | 16 | $595 |
| Nadolol | 12 | $499 |
| Verapamil ErVerapamil Hcl | 17 | $440 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $268 | $663,906544 claims |
| Johnson & JohnsonXarelto | $179 | $195,586160 claims |
| Sanofi-aventis U.S. LLCMultaq | $130 | $32,93215 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 60th percentile of 93 clinical cardiac electrophysiology providers in Georgia.
Other clinical cardiac electrophysiology in Marietta
- Michael RileyMarietta$121K
- Bryan PiedadMarietta$103K
- Cesar EgoavilMarietta$17K
- David DelurgioAtlanta$695K
- Thomas DeeringAtlanta$237K
- David NewtonSavannah$225K
- Michael LloydAtlanta$221K
- Kent NilssonAthens$198K
- Mikhael El-ChamiAtlanta$172K
- Sandeep GoyalAtlanta$153K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.